XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities    
Net income (loss) $ 75,839 $ (137,097)
Adjustments to reconcile net income (loss) to operating activities:    
Amortization, depreciation and write-offs 248,100 281,677
Stock-based compensation 164,219 101,796
Amortization of debt issuance costs and discount 6,583 6,820
Change in operating right-of-use asset 6,893 10,558
Other (1,017) 478
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 33,271 (163,416)
Prepaid expenses and other current assets (2,111) (28,993)
Other assets (3,017) 3,033
Accounts payable (12,265) 13,773
Operating lease liabilities (7,104) (12,046)
Accrued and other liabilities (1,033) 7,795
Deferred revenue 10,098 (9,286)
Net cash provided by operating activities 518,456 75,092
Investing Activities    
Acquisitions, net of cash acquired (38,356) (1,294,352)
Purchase of non-marketable equity securities (16,834) (56,546)
Capitalized software development costs (4,433) (2,608)
Purchase of property and equipment (3,819) (400)
Proceeds from sale of assets 8,250 2,162
Net cash used in investing activities (55,192) (1,351,744)
Financing Activities    
Repurchases of stock (572,101) (244,015)
Payment of withholding taxes related to net share settlement (56,603) 0
Principal repayments of debt (16,656) (9,155)
Payments of licensed asset obligation (15,254) (17,374)
Principal payments on finance leases (10,915) (12,326)
Payment of debt issuance cost (3,961) 0
Payments of deferred acquisition costs (1,229) (71,712)
Proceeds from exercise of stock options 6,535 15,873
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 2,071 3,663
Net cash used in financing activities (668,113) (335,046)
Effect of foreign exchange rate on cash and cash equivalents 592 (7,246)
Net (decrease) in cash and cash equivalents (204,257) (1,618,944)
Cash, cash equivalents and restricted cash equivalents at beginning of the period 1,080,484 2,570,504
Cash and cash equivalents at end of the period 876,227 951,560
Supplemental non-cash investing and financing activities disclosures:    
Right-of-use assets acquired under finance leases 45,564 17,869
Right-of-use assets acquired under operating leases 4,001 1,385
Repurchases of common stock included in accrued liabilities 7,705 10,512
Acquisitions not yet paid 7,463 70,792
Issuance of common stock in connection with acquisitions 0 137,422
Supplemental disclosure of cash flow information:    
Cash paid for interest, net 118,948 61,867
Cash paid for income taxes, net of refunds $ 6,808 $ 19,529